Tiqun Yang
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long noncoding RNA CARDINAL cis-activates MYOCD expression by recruiting histone reader ZZZ3 in vascular smooth muscle cell phenotype alteration.
Journal: Cardiovascular research
Published: August 18, 2025
The long noncoding RNA CARDINAL attenuates cardiac hypertrophy by modulating protein translation.
Journal: The Journal of clinical investigation
Published: January 25, 2023
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure.
Journal: Frontiers in cardiovascular medicine
Published: January 18, 2022
Circle the Cardiac Remodeling With circRNAs.
Journal: Frontiers in cardiovascular medicine
Published: April 29, 2021
Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy.
Journal: Frontiers in cell and developmental biology
Published: January 07, 2021
The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 17, 2020
An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 02, 2020
Transcribed Ultraconserved Regions, Uc.323, Ameliorates Cardiac Hypertrophy by Regulating the Transcription of CPT1b (Carnitine Palmitoyl transferase 1b).
Journal: Hypertension (Dallas, Tex. : 1979)
Published: November 19, 2019
Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2.
Journal: Theranostics
Published: January 10, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026